Veracyte, Inc.(VCYT)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
VCYT | 3.47 B | 32.21x | 15.50% | 20.37% | $1.34 | 8.77% | 2.89x | 0.00% | $60.91 | $29.46 |
TMO | 244.79 B | 36.90x | 10.50% | 15.04% | $17.94 | 13.52% | 0.81x | 0.28% | $683.63 | $434.50 |
NTRA | 57.02 B | - | 37.70% | -7.11% | -$1.35 | -12.54% | 0.13x | 0.00% | $427.47 | $157.43 |
ILMN | 40.43 B | 49.96x | 9.40% | 18.34% | $5.36 | 32.34% | 0.89x | 0.00% | $280.17 | $88.00 |
GH | 22.59 B | - | 44.30% | -38.33% | -$3.44 | - | - | 0.00% | $183.51 | $60.45 |
Peer Valuation & Performance Analysis
Peer group analysis for Veracyte, Inc. (VCYT) compared to its primary competitors (including TMO, NTRA, ILMN) reveals distinct metrics. VCYT trades at a valuation premium compared to its competitors, with a P/E ratio of 32.2x versus the peer average of -63.8x (representing a -151% premium). This indicates that the market expects superior growth or commands a quality premium for VCYT. In terms of growth, VCYT's revenue growth of 15.5% lags behind the peer average of 25.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 20.4% compared to the peer average of -3.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• VCYT ranks #1 in P/E ratio, #3 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $44.04 | $44.21 | $42.34 | $43.16 | 1,213,600 | -3.34% |
| 2026-10-06 | $48.00 | $48.84 | $44.09 | $44.65 | 1,730,800 | -6.34% |
| 2026-10-05 | $45.75 | $47.78 | $45.00 | $47.67 | 1,289,100 | +4.06% |
| 2026-10-02 | $44.94 | $46.09 | $44.41 | $45.81 | 1,041,700 | +3.67% |
| 2026-10-01 | $45.66 | $47.14 | $44.18 | $44.19 | 1,426,700 | -4.02% |
| 2026-09-30 | $45.93 | $46.78 | $45.60 | $46.04 | 1,184,200 | -0.09% |
| 2026-09-29 | $46.00 | $47.52 | $45.21 | $46.08 | 1,594,800 | +1.88% |
| 2026-09-28 | $45.04 | $47.52 | $44.47 | $45.23 | 1,696,500 | -0.44% |
| 2026-09-25 | $49.00 | $49.00 | $45.36 | $45.43 | 1,725,700 | -6.41% |
| 2026-09-24 | $43.66 | $48.95 | $43.51 | $48.54 | 2,880,200 | +10.77% |
| 2026-09-23 | $42.95 | $43.86 | $42.25 | $43.82 | 1,525,500 | +1.06% |
| 2026-09-22 | $41.76 | $43.74 | $41.31 | $43.36 | 1,472,500 | +4.43% |
| 2026-09-21 | $40.00 | $41.98 | $39.40 | $41.52 | 1,470,500 | +4.33% |
| 2026-09-18 | $40.41 | $41.05 | $39.55 | $39.80 | 2,667,600 | -1.91% |
| 2026-09-17 | $39.67 | $40.70 | $38.80 | $40.57 | 1,470,300 | +5.38% |
Explore More Analysis for VCYT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.